VANGUARD GROUP INC - BENITEC BIOPHARMA INC ownership

BENITEC BIOPHARMA INC's ticker is BNTC and the CUSIP is 08205P100. A total of 18 filers reported holding BENITEC BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of BENITEC BIOPHARMA INC
ValueSharesWeighting
Q2 2023$17,833
+13.6%
74,7730.0%0.00%
Q1 2023$15,695
+23.5%
74,7730.0%0.00%
Q4 2022$12,711
-54.6%
74,7730.0%0.00%
Q3 2022$28,000
-69.2%
74,773
-4.6%
0.00%
Q2 2022$91,000
-50.3%
78,3710.0%0.00%
Q1 2022$183,000
-10.7%
78,3710.0%0.00%
Q4 2021$205,000
-26.8%
78,3710.0%0.00%
Q3 2021$280,000
-11.9%
78,371
+4.8%
0.00%
Q2 2021$318,000
+17.8%
74,773
+43.3%
0.00%
Q1 2021$270,00052,1940.00%
Other shareholders
BENITEC BIOPHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 498,009$1,778,0001.00%
SUVRETTA CAPITAL MANAGEMENT, LLC 769,000$2,745,0000.05%
WealthTrust Axiom LLC 12,950$46,0000.02%
Private Wealth Advisors, LLC 15,043$49,0000.01%
Virtu Financial LLC 22,924$82,0000.01%
UBS Group AG 1,061$4,0000.00%
BANK OF AMERICA CORP /DE/ 91$00.00%
WELLS FARGO & COMPANY/MN 41$00.00%
NORTHERN TRUST CORP 11,813$42,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BENITEC BIOPHARMA INC shareholders